Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Praecis submits IND to begin phase I trial of PPI-2458 in NHL

April 22, 2003

A humanized anti-EGFR monoclonal antibody reported safe in advanced epithelial cancer

April 22, 2003

Triapine evaluated clinically in combination with cytarabine for leukemia

April 22, 2003

Macrocyclic modulators of c-fos expression and their use in cancer therapy

April 22, 2003

Antitumor acridine derivatives prepared and tested at Servier

April 22, 2003

Novel 17beta-HSD type 3 inhibitors and their use in cancer and prostate disorders

April 17, 2003

Ribozyme concludes Medizyme joint venture with Elan

April 16, 2003

Several series of B-Raf kinase inhibitors discovered at GSK

April 16, 2003

New Tie-2 and/or VEGFR2 kinase inhibitors prepared and tested by GSK scientists

April 16, 2003

OSI updates Tarceva program progress

April 15, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...